Last reviewed · How we verify

MEPIVACAÍNE

Complexo Hospitalario Universitario de A Coruña · FDA-approved active Small molecule

Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses. Used for Local and regional anesthesia for dental procedures, Local and regional anesthesia for minor surgical procedures, Infiltration anesthesia.

At a glance

Generic nameMEPIVACAÍNE
Also known asMEPIVACAINE 2% ATC N01BB03 MAN 62606
SponsorComplexo Hospitalario Universitario de A Coruña
Drug classLocal anesthetic (amide)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Mepivacaine reversibly inhibits sodium influx into nerve fibers by binding to sodium channels from the intracellular side, thereby stabilizing the neuronal membrane and raising the threshold for electrical excitability. This action prevents depolarization and propagation of action potentials, resulting in local anesthesia. The drug is an amide-type local anesthetic with intermediate duration of action.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results